These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2192445)

  • 21. Aldosterone and other mineralocorticoids in Bartter's syndrome.
    Saruta T; Fujimaki M; Senba S; Saito I; Konishi K
    J Lab Clin Med; 1984 Jun; 103(6):848-53. PubMed ID: 6373989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The therapeutic use of a new potassium-sparing diuretic, amiloride, and a converting enzyme inhibitor, MK-421, in preventing hypokalemia associated with primary and secondary hyperaldosteronism.
    Griffing GT; Melby JC
    Clin Exp Hypertens A; 1983; 5(6):779-801. PubMed ID: 6309436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Familial Bartter's syndrome and the effect of indomethacin in one family member.
    Tsunoda S; Tsushima T; Nishioka T; Ohno N; Fukunaga T; Takano K; Yumura W; Shizume K; Branch RA
    J Urol; 1982 May; 127(5):1000-5. PubMed ID: 7086975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of indomethacin on the vascular abnormalities of Bartter's syndrome.
    Richards CJ; Mark AL; Van Orden DE; Kaloyanides GJ
    Circulation; 1978 Sep; 58(3 Pt 1):544-9. PubMed ID: 679446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term follow-up of a girl with the neonatal form of Bartter's syndrome.
    Nakagawa Y; Toya K; Natsume H; Nasuda K; Takeuchi H; Kubota A; Ogawa H; Igarashi Y
    Endocr J; 1997 Apr; 44(2):275-81. PubMed ID: 9228463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Bartter's syndrome].
    Linnanvuo-Laitinen M; Pirttiaho H; Huttunen K; Viinikka L
    Duodecim; 1985; 101(20):1983-6. PubMed ID: 4085359
    [No Abstract]   [Full Text] [Related]  

  • 27. The effect of long-term treatment with spironolactone on sodium pump abnormalities in the red blood cells of patients with Bartter's syndrome.
    Horký K; Schreiber V; Dvoráková J
    Exp Clin Endocrinol; 1984 Jul; 84(1):105-11. PubMed ID: 6090182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of Sar1-ala8-angiotensin II on blood pressure and renin in Bartter's syndrome, before and after treatment with prostaglandin synthetase inhibitors.
    Rudin A; Aurell M; Hansson L; Westberg G
    Scand J Clin Lab Invest; 1979 Oct; 39(6):543-50. PubMed ID: 119300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Total body potassium in Bartter's syndrome before and during treatment with enalapril.
    van de Stolpe A; Verhoef GE; Hené RJ; Koomans HA; van der Vijver JC
    Nephron; 1987; 45(2):122-5. PubMed ID: 3031521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term use of propranolol, ibuprofen, and spironolactone in the management of Bartter's syndrome.
    Cunningham RJ; Brouhard BH; Berger M; Petrusick T; Travis LB
    Pediatrics; 1979 May; 63(5):754-6. PubMed ID: 440896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renin-angiotensin-aldosterone system of a woman with Bartter's syndrome: Juxtaglomerular cell hyperplasia without hypertension.
    Nakada T; Momose G; Yoshida T; Tateno Y; Shigematsu H
    J Urol; 1974 Sep; 112(3):293-8. PubMed ID: 4369140
    [No Abstract]   [Full Text] [Related]  

  • 32. Prostaglandins and Bartter's syndrome.
    Dunn MJ
    Kidney Int; 1981 Jan; 19(1):86-102. PubMed ID: 7012423
    [No Abstract]   [Full Text] [Related]  

  • 33. Indomethacin in Bartter's syndrome: does the syndrome represent a state of hyperprostaglandinism?
    Donker AJ; de Jong PE; van Eps LW; Brentjens JR; Bakker K; Doorenbos H
    Nephron; 1977; 19(4):200-13. PubMed ID: 917167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypotensive response to angiotensin II analogue and angiotensin I converting enzyme inhibitor in pseudo-Bartter's syndrome.
    Sasaki H; Kawasaki T; Fujisawa M; Motooka Y; Asano T; Okumura M
    Jpn Heart J; 1981 Jul; 22(4):689-93. PubMed ID: 6272003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Increased renal prostaglandin E2 secretion in Bartter's syndrome].
    Schwarz HA; Weidmann P; Messerli FH; Zia PK; Flammer J; Reubi RC
    Schweiz Med Wochenschr; 1977 Dec; 107(49):1870-2. PubMed ID: 929154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. On the pathogenetic role of prostaglandins in Bartter's syndrome.
    Nielsen I; Hesse B; Christensen P
    Acta Med Scand Suppl; 1979; 625():135-40. PubMed ID: 285569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of Bartter's syndrome in early childhood with prostaglandin synthetase inhibitors.
    Littlewood JM; Lee MR; Meadow SR
    Arch Dis Child; 1978 Jan; 53(1):43-8. PubMed ID: 415668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A case of adult-onset Bartter's syndrome.
    Park JW; Chung YJ; Yeum CH; Lee JJ; Yoo KS; Kim SW; Kim NH; Choi KC; Kang YJ
    Korean J Intern Med; 1995 Jan; 10(1):60-3. PubMed ID: 7626559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correction of hypokalemia in Bartter's syndrome by enalapril.
    Hené RJ; Koomans HA; Dorhout Mees EJ; vd Stolpe A; Verhoef GE; Boer P
    Am J Kidney Dis; 1987 Mar; 9(3):200-5. PubMed ID: 3030096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Indomethacin for Bartter's syndrome.
    Zancan L; Zacchello F; Mantero F
    Lancet; 1976 Dec; 2(7999):1354. PubMed ID: 63823
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.